Bellevue Group’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-24
| Closed | -$151K | – | 143 |
|
|
2018
Q2 | $151K | Sell |
24
-3
| -11% | -$18.9K | 0.01% | 138 |
|
|
2018
Q1 | $347K | Hold |
27
| – | – | 0.03% | 124 |
|
|
2017
Q4 | $1.28M | Hold |
27
| – | – | 0.13% | 99 |
|
|
2017
Q3 | $1.78M | Hold |
27
| – | – | 0.19% | 83 |
|
|
2017
Q2 | $1.55M | Hold |
27
| – | – | 0.18% | 91 |
|
|
2017
Q1 | $2M | Hold |
27
| – | – | 0.27% | 79 |
|
|
2016
Q4 | $2.32M | Hold |
27
| – | – | 0.48% | 56 |
|
|
2016
Q3 | $3.75M | Hold |
27
| – | – | 0.68% | 49 |
|
|
2016
Q2 | $9.09M | Hold |
27
| – | – | 1.71% | 17 |
|
|
2016
Q1 | $7.9M | Buy |
+27
| New | +$7.9M | 1.43% | 20 |
|